NEWS

Vitamin Pills May Be Bad for You

We dose up on antioxidants as if they are the elixir of life. At best, they are probably ineffective. At worse, they may just send you to an early grave. For Linus Pauling, it all started to go wrong when he changed his breakfast routine. In 1964, at the age of 65, he started adding […]

Stem cell transplant slows down MS progression

A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple sclerosis than other existing therapies. Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is a chronic neurodegenerative condition […]

Integrase inhibitors give greater chance of viral suppression in pregnant women

  Integrase inhibitors give greater chance of viral suppression at delivery in pregnant women   Jump to Raltegravir-based ART started in pregnancy Dolutegravir-based ART started in late pregnancy References Integrase inhibitor-based treatment with either raltegravir (Isentress) or dolutegravir (Tivicay, also in Triumeq) reduces viral load more rapidly than efavirenz if started in pregnancy, findings from two randomised […]

Excessive daily TV at older age tied to poorer memory

Older people who want to preserve their faculties may wish to consider rationing their TV time. A large new study of older adults found that those who spent at least 3.5 hours per day watching TV experienced a greater decline in verbal memory. The ‘passive activity’ of watching TV may impair memory in older people. […]

HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption

HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption An HIV-positive man transmitted HIV to his sexual partner after interrupting antiretroviral therapy as part of a research study into a therapeutic vaccine, French scientists reported in the Journal of Infectious Diseases last week. The case report underlines the importance of participants […]

Keytruda combination(Inlyta) found to reduce risk of death in RCC – Renal Cell Carcinoma

A combination of MSD’s anti-PD-1 therapy Keytruda (pembrolizumab) and Pfizer’s tyrosine kinase inhibitor Inlyta (axitinib) has been found to reduce risk of death by nearly half compared to sunitinib as first-line treatment for advanced renal cell carcinoma (RCC). The results are taken from the pivotal Phase III KEYNOTE-426 trial, and show that the combination is […]